Blockchain Registration Transaction Record

Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (NASDAQ: ACOG) and Highlights Progress in 2024

Stonegate Capital Partners initiates coverage on Alpha Cognition Inc. (NASDAQ: ACOG) and its flagship Alzheimer's therapy ZUNVEYL. With FDA approval and upcoming launch, Alpha Cognition aims to provide a well-tolerated treatment option for Alzheimer's patients, addressing the high discontinuation rate due to side effects.

Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (NASDAQ: ACOG) and Highlights Progress in 2024

This news matters as Alpha Cognition's innovative Alzheimer's therapy ZUNVEYL has the potential to address the unmet needs in the treatment of AD. With a strong management team, financial stability, and global expansion plans, Alpha Cognition is positioned for rapid adoption and long-term success in the market.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x149d3b22328b0df6c5e8f2ef3db1224fb9ffc43182fedd24b2604d56cfd4eadf
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintcamcXRsK-5d19ee71eb0ed27207e879f801ce58d8